The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 study of pembrolizumab plus lenvatinib or pembrolizumab coformulated with vibostolimab in participants (pts) with metastatic neuroendocrine prostate cancer (NEPC): KEYNOTE-365 cohorts F and H.
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Janssen; Lilly Medical; Merck; Merck Serono; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck Serono; Pfizer/EMD Serono; Roche
 
Martin Boegemann
Employment - Janssen; Janssen
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; Janssen-Cilag
 
Johann De Bono
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; ImCheck therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Acai Therapeutics; Amgen; Amunix (Inst); Astellas Pharma; AstraZeneca; Bayer; BioXCel therapeutics (Inst); Boehringer Ingelheim (Inst); CellCentric; Crescendo Biologics (Inst); Daiichi Sankyo; Dark Blue Therapeutics (Inst); Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; Harpoon therapeutics; ImCheck therapeutics; Immunic Therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; MetaCurUm; Myricx Pharma; Novartis; Nurix (Inst); Oncternal Therapeutics; Orion; Pfizer (Inst); Qiagen; Sanofi Aventis GmbH (Inst); Sierra Oncology; Taiho Oncology; Takeda (Inst); Tango Therapeutics (Inst)
Speakers' Bureau - AstraZeneca
Research Funding - Amgen (Inst); AstraZeneca (Inst); CellCentric (Inst); Crescendo Biologics (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunic Therapeutics (Inst); Janssen (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MetaCurUm (Inst); MorphoSys (Inst); Myricx (Inst); Nurix (Inst); Oncternal Therapeutics (Inst); Orion (Inst); Pfizer (Inst); Sanofi Aventis GmbH (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); CHK1 inhibitor (Inst); PARP inhibitors and DNA repair defects (Inst); Targeting of IL23 in prostate cancer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bayer; Cellcentric; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Halda Therapeutics; Merck Serono; Merck Sharp & Dohme; Orion; Pfizer; Sanofi
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Speakers' Bureau - Bureau Prevents; Ismar Healthcare; Medtalks; TCM healthcare
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ipsen; Merck Serono
 
Josep Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Clovis Oncology; IDEAYA Biosciences; Immunocore; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Immunocore; Incyte; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Pfizer/EMD Serono
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche
 
Alexandra Drakaki
Employment - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I); Dyania Health (I)
Leadership - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Athos Therapeutics (I); ATTICA SCIENCES; Dyania Health (I); Kyn therapeutics (I); Moderna Therapeutics (I); PROTEAS BIOANALYTICS (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; AVEO; Bristol-Myers Squibb; Daichi-Sanchyo; DYANIA HEALTH; EMD Serono; EMD Serono; Exelixis; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; PACT Pharma; RADMETRIX; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Infinity Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Kite/Gilead; Merck Sharp & Dohme (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
Patents, Royalties, Other Intellectual Property - My significant other has several patents with UCLA, Harvard Medical School, Athos Therapeutics, Proteas Bioanalytics and ATTICA Sciences (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Seagen
 
Debbie Robbrecht
Honoraria - Springer
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Axiom Healthcare Strategies; BMS; Gilead Sciences (Inst); J&J (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Merck KGaA (Inst)
 
Mariusz Kwiatkowski
No Relationships to Disclose
 
Elizabeth Kessler
Honoraria - Astellas Scientific and Medical Affairs Inc
Research Funding - Bristol-Myers Squibb (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst)
 
Urban Emmenegger
Honoraria - Amgen; Apobiologix; Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Tersera
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Therapeutics; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Tersera
Research Funding - Astellas Pharma; Bayer; Janssen
 
Cagatay Arslan
Consulting or Advisory Role - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Speakers' Bureau - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Research Funding - Roche, Novartis, BMS, Merck, MSD, Astra Zeneca, Nektar, Johnson &Johnson, Lilly, Amgen, Incyte, Bayer, Yuhan, Henlius, Pfizer, Biontech, Genmab, Beigene, GSK
 
Gedske Daugaard
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Bayer; Merck
 
Enrique Castellanos
No Relationships to Disclose
 
Christopher Wee
Consulting or Advisory Role - Alphasights; Aptitude Health; Atheneum; Bayer HealthCare Pharmacuticals; Capvision; ClarityCo; Curio Science; DocDelta; Fennec Pharma; GLG Insights; Johnson and Johnson; MJH Life Sciences; Pfizer; The Dedham Group
Research Funding - Merck
 
Lockman Bousserouel
Employment - MSD
Stock and Other Ownership Interests - MSD
 
Charles Schloss
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kentaro Imai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Evan Y. Yu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Johnson and Johnson; Lantheus Medical Imaging; Merck; Novartis; Tolmar
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Pfizer (Inst); Tyra Biosciences (Inst)